Bridge Biotherapeutics Correlations
| 288330 Stock | KRW 3,940 120.00 2.96% |
The current 90-days correlation between Bridge Biotherapeutics and KNOTUS CoLtd is 0.09 (i.e., Significant diversification). The correlation of Bridge Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Bridge Biotherapeutics Correlation With Market
Good diversification
The correlation between Bridge Biotherapeutics and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bridge Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
Bridge |
The ability to find closely correlated positions to Bridge Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bridge Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bridge Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bridge Biotherapeutics to buy it.
Moving together with Bridge Stock
| 0.84 | 293780 | AptaBio Therapeutics | PairCorr |
| 0.67 | 225220 | Genolution | PairCorr |
| 0.64 | 254120 | Xavis Co | PairCorr |
| 0.66 | 353190 | Hurum | PairCorr |
| 0.61 | 336570 | Daishin Balance No8 | PairCorr |
| 0.8 | 034830 | Korea Real Estate | PairCorr |
Moving against Bridge Stock
| 0.56 | 041510 | SM Entertainment | PairCorr |
| 0.56 | 032640 | LG Uplus | PairCorr |
| 0.54 | 035420 | Naver | PairCorr |
| 0.39 | 078160 | MEDIPOST | PairCorr |
| 0.36 | 011390 | Busan Industrial | PairCorr |
| 0.61 | 014940 | Oriental Precision | PairCorr |
| 0.61 | 003535 | Hanwha InvestmentSecuri | PairCorr |
| 0.59 | 035900 | JYP Entertainment | PairCorr |
| 0.57 | 122870 | YG Entertainment | PairCorr |
| 0.57 | 205470 | Humasis | PairCorr |
| 0.53 | 003490 | Korean Air Lines | PairCorr |
| 0.43 | 153460 | Nable Communications | PairCorr |
| 0.39 | 071055 | Korea Investment Holdings | PairCorr |
| 0.37 | 003920 | Namyang Dairy | PairCorr |
Related Correlations Analysis
| 0.34 | 0.58 | 0.36 | 0.74 | 0.79 | 278650 | ||
| 0.34 | 0.84 | 0.48 | 0.67 | 0.54 | 288330 | ||
| 0.58 | 0.84 | 0.56 | 0.89 | 0.82 | 293780 | ||
| 0.36 | 0.48 | 0.56 | 0.59 | 0.54 | 217330 | ||
| 0.74 | 0.67 | 0.89 | 0.59 | 0.9 | 225220 | ||
| 0.79 | 0.54 | 0.82 | 0.54 | 0.9 | 215380 | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Bridge Stock performing well and Bridge Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bridge Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 278650 | 1.91 | (0.24) | 0.00 | 1.63 | 0.00 | 3.45 | 22.28 | |||
| 288330 | 5.78 | 0.26 | 0.04 | (0.36) | 5.84 | 14.21 | 41.45 | |||
| 293780 | 2.76 | (0.52) | 0.00 | 1.70 | 0.00 | 5.01 | 19.84 | |||
| 217330 | 3.98 | (0.12) | 0.00 | 0.17 | 0.00 | 7.93 | 34.84 | |||
| 225220 | 1.77 | (0.51) | 0.00 | 1.44 | 0.00 | 3.70 | 9.90 | |||
| 215380 | 3.17 | (0.43) | 0.00 | (2.27) | 0.00 | 6.11 | 39.08 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bridge Biotherapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Bridge Biotherapeutics Corporate Management
Elected by the shareholders, the Bridge Biotherapeutics' board of directors comprises two types of representatives: Bridge Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bridge. The board's role is to monitor Bridge Biotherapeutics' management team and ensure that shareholders' interests are well served. Bridge Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bridge Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Taeksang Park | VP CFO | Profile | |
| Gwanghee Lee | VP Director | Profile | |
| SangUk Kang | VP Director | Profile | |
| James Lee | CEO Director | Profile |